Kepler Capital Remains a Hold on Koninklijke Philips (PHG)


Kepler Capital analyst Andreas Schneider maintained a Hold rating on Koninklijke Philips (PHG) yesterday and set a price target of EUR44.00. The company’s shares closed last Monday at $52.10, close to its 52-week high of $52.83.

According to TipRanks.com, Schneider is ranked #6538 out of 6793 analysts.

Currently, the analyst consensus on Koninklijke Philips is a Moderate Buy with an average price target of $50.30.

See today’s analyst top recommended stocks >>

Based on Koninklijke Philips’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.16 billion and net profit of $38 million. In comparison, last year the company earned revenue of $4.15 billion and had a net profit of $164 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Read More on PHG:

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts